Transforming Canada's role in global cancer control.


Journal

The Lancet. Oncology
ISSN: 1474-5488
Titre abrégé: Lancet Oncol
Pays: England
ID NLM: 100957246

Informations de publication

Date de publication:
09 2021
Historique:
received: 08 03 2021
revised: 11 06 2021
accepted: 17 06 2021
pubmed: 4 9 2021
medline: 22 9 2021
entrez: 3 9 2021
Statut: ppublish

Résumé

Cancer has not been an explicit priority of Canada's international health and development agenda, but it is key to realising the country's Sustainable Development Goal commitments. Multiple converging political, health, and social forces could now drive support for a more integrated Canadian approach to global cancer control. Success will depend on the extent to which Canadian leaders and institutions can build consensus as a community and agree to work together. Collaboration should include agreement on the framing and prioritisation of the core issues, building a broad coalition base, aligning with priorities of international partners, and on a governance structure that reflects the principles of equity, diversity, and inclusion. This Series paper will discuss global cancer control within Canada's global health agenda, how Canada can address its history of colonisation and present-day disparities in its global work, and the challenges and opportunities of creating a Canadian global cancer control network.

Identifiants

pubmed: 34478676
pii: S1470-2045(21)00374-0
doi: 10.1016/S1470-2045(21)00374-0
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e400-e409

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests SG reports personal fees from Jazz Pharmaceuticals, outside the submitted work. All other authors declare no competing interests.

Auteurs

Danielle Rodin (D)

Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. Electronic address: danielle.rodin@rmp.uhn.ca.

Anna J Dare (AJ)

Centre for Global Health Research, St Michael's Hospital, Toronto, ON, Canada.

Reanne Booker (R)

Palliative and End-of-Life Care Services-Calgary Zone, Calgary, AB, Canada.

Christopher Booth (C)

Department of Oncology, Queen's University, Kingston, ON, Canada.

Heather Bryant (H)

Canadian Partnership Against Cancer, Toronto, ON, Canada.

Ophira Ginsburg (O)

Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Population Health and Perlmutter Cancer Centre, NYU Grossman School of Medicine, New York, NY, USA.

Meredith Giuliani (M)

Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.

Mary Gospodarowicz (M)

Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.

Sumit Gupta (S)

Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.

Nazik Hammad (N)

Department of Oncology, Queen's University, Kingston, ON, Canada.

Zeev Rosberger (Z)

Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada.

Simon Sutcliffe (S)

Two Worlds Cancer Collaboration, Kelowna, BC, Canada.

Craig C Earle (CC)

Canadian Partnership Against Cancer, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH